The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引：0
作者：
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构：
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1696
引用
收藏
页数：6
相关论文
共 50 条
[31]   Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients [J].
Gambale, Carla ;
Prete, Alessandro ;
Contartese, Lea ;
Torregrossa, Liborio ;
Bianchi, Francesca ;
Molinaro, Eleonora ;
Materazzi, Gabriele ;
Elisei, Rossella ;
Matrone, Antonio .
EUROPEAN THYROID JOURNAL, 2023, 12 (06)
[32]   Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma [J].
Jing-Jia Cao ;
Can-Hua Yun ;
Juan Xiao ;
Yong Liu ;
Wei Wei ;
Wei Zhang .
World Journal of Clinical Cases, 2021, (36) :11173-11182
[33]   The study of influence factors on 131I treatment of differentiated thyroid carcinoma with lymph node metastases [J].
Ye, Zhi-Yi ;
Wang, Hui ;
Fu, Hong-Liang ;
Li, Jia-Ning ;
Zou, Ren-Jian ;
Gu, Zhen-Hui ;
Wu, Jing-Chuan .
CLINICAL IMAGING, 2009, 33 (03) :221-225
[34]   Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma [J].
Cao, Jing-Jia ;
Yun, Can-Hua ;
Xiao, Juan ;
Liu, Yong ;
Wei, Wei ;
Zhang, Wei .
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (36) :11173-11182
[35]   Significance of Salivary Gland Radioiodine Retention on Post-ablation 131I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma [J].
Jo K.S. ;
An Y.-S. ;
Lee S.J. ;
Soh E.-Y. ;
Lee J. ;
Chung Y.-S. ;
Kim D.J. ;
Yoon S.-H. ;
Lee D.H. ;
Yoon J.-K. .
Nuclear Medicine and Molecular Imaging, 2014, 48 (3) :203-211
[36]   Absorbed dose to the salivary glands in thyroid patients undergoing treatment with I-131. [J].
ElShirbiny, A ;
Imbriaco, M ;
Yeung, H ;
Furhang, EE ;
Humm, JL ;
Yeh, SDJ ;
ODonoghue, JA ;
Macapinlac, H ;
Robbins, R ;
Larson, SM .
JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) :399-399
[37]   Effect of first 131I treatment on salivary gland function in patients with differentiated thyroid cancer coexisted with Hashimoto's thyroiditis [J].
Pang Xiaoan ;
Wei Zhixiao .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62
[38]   Practical dosimetry of 131I in patients with thyroid carcinoma [J].
Sisson, JC .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (01) :101-105
[39]   Efficacy and Affecting Factors of 131I Thyroid Remnant Ablation After Surgical Treatment of Differentiated Thyroid Carcinoma [J].
Wang, Chen ;
Diao, Hongcui ;
Ren, Ping ;
Wang, Xufu ;
Wang, Yangang ;
Zhao, Wenjuan .
FRONTIERS IN ONCOLOGY, 2018, 8
[40]   Clinical features of patients with recurrent or metastatic differentiated thyroid carcinoma after 131I therapy [J].
蔡晓雨 .
ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (04) :205-206
12345